|
Quotes & Info
|
| NWBO > SEC Filings for NWBO > Form 8-K on 7-Dec-2012 | All Recent SEC Filings |
7-Dec-2012
Other Events, Financial Statements and Exhibits
On December 7, 2012, Northwest Biotherapeutics, Inc. (the "Company") issued a press release announcing the pricing of its public offering of 3,000,000 shares of common stock and warrants to purchase up to 1,500,000 shares of common stock, at an offering price of $4.00 per share of common stock and $0.01 per warrant. The press release also announced the listing of the Company's common stock and warrants on The NASDAQ Capital Market under the symbols "NWBO" and "NWBOW," respectively. A copy of the press release is attached hereto as Exhibit 99.1.
(d) Exhibits
99.1 Press Release dated December 7, 2012
|
|